Wilson Sonsini Advises Foresight on Roche Settlement and Licensing Agreement
On August 29, 2025, Foresight Diagnostics, a privately held cancer diagnostics company and CLIA-registered laboratory, announced that it…
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
Novartis NOVN 1.69%increase; green up pointing triangle said it agreed to buy biotech company Excellergy for up to…
UK-Swiss trade deal held up over pharma row – POLITICO
The Swiss are “very angry, understandably, and [the pharmaceutical] industry are angry, because the U.K. has turned around…
Abusive pharma patents: Roche’s “mAb” empire
This summer, Roche followed the same playbook for another of its cancer drugs, Lunsumio. As of early November,…